Feed Symbols: ANIP

ANI Pharmaceuticals (NASDAQ:ANIP) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $0.09 by 233.33 percent. This is a 111.54 percent decrease over earnings of $1.04 per share

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 350 points on Tuesday.

 

ANI Pharmaceuticals Inc’s (NASDAQ:ANIP) Q4 revenues were $60.9 million, +6.4% Y/Y, beating the consensus of $56.30 million. Net revenues for…

Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments served as catalysts during the week.

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) (ANI or the Company) today announced the U.S. commercial availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) 80 U/mL. The commercial launch of

-Dow Jones

Here's a roundup of top developments in the biotech space over the last 24 hours: